• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用高分辨率MRI定量直肠周围脂肪含量预测中低位直肠癌的异时性肝转移

Prediction of metachronous liver metastasis in mid-low rectal cancer using quantitative perirectal fat content from high-resolution MRI.

作者信息

Qin Jiaming, Dong Wenjin, Zhao Fengshu, Liu Tianqi, Chen Mengxin, Zhang Rui, Zhao Yumeng, Zhang Cheng, Wang Wenhong

机构信息

The School of Medicine, Nankai University, Tianjin, China.

Tianjin Union Medical Center, Nankai University, Tianjin, China.

出版信息

Magn Reson Imaging. 2025 May;118:110338. doi: 10.1016/j.mri.2025.110338. Epub 2025 Jan 29.

DOI:10.1016/j.mri.2025.110338
PMID:39889974
Abstract

PURPOSE

To investigate the relationship between perirectal fat content and metachronous liver metastasis (MLM) in patients with Mid-low rectal cancer (MLRC).

MATERIALS AND METHODS

A retrospective analysis was conducted on 254 patients who underwent curative surgery for MLRC between December 2016 and December 2021. Preoperative MRI measurements of the rectal mesenteric fat area (MFA), rectal posterior mesorectal thickness (PMT), and rectal mesenteric fascia envelopment volume (MFEV) were performed, along with collection of relevant clinical, pathological, and imaging data. Patients were categorized into the MLM group (Group A), other recurrence or metastasis group (Group B), and no recurrence and metastasis group (Group C). Analyze the differences between Group A and the other groups, and independent risk factors for MLM were explored. Kaplan-Meier analysis and log-rank test were used to validate independent predictive biomarkers for MLM.

RESULTS

Patients with MLM from MLRC had later pathological and imaging T stages and lower perirectal fat content (all P < 0.05). Compared to patients with other types of recurrent metastasis, male gender, poorly differentiated tumors, and advanced tumor N stage were more likely to develop MLM (all P < 0.05). In Cox univariate and multivariate regression analysis, smaller rectal PMT (hazard ratio (HR) 0.361 [0.154-0.846], P = 0.019) and MFEV (HR 0.983 [0.968-0.998], P = 0.022) were independently associated with MLM in MLRC (HR 0.361;0.983). Kaplan-Meier analysis showed that patients with rectal PMT <1.43 cm and rectal MFEV <137.46 cm had a significantly higher risk of MLM compared to patients with rectal PMT ≥1.43 cm and rectal MFEV ≥137.46 cm (all P < 0.05).

CONCLUSION

Rectal PMT and rectal MFEV can serve as novel parameters for predicting MLM in patients with MLRC.

摘要

目的

探讨中低位直肠癌(MLRC)患者直肠周围脂肪含量与异时性肝转移(MLM)之间的关系。

材料与方法

对2016年12月至2021年12月期间接受根治性手术的254例MLRC患者进行回顾性分析。术前通过MRI测量直肠系膜脂肪面积(MFA)、直肠后系膜厚度(PMT)和直肠系膜筋膜包绕体积(MFEV),并收集相关临床、病理和影像资料。将患者分为MLM组(A组)、其他复发或转移组(B组)和无复发转移组(C组)。分析A组与其他组之间的差异,探讨MLM的独立危险因素。采用Kaplan-Meier分析和对数秩检验验证MLM的独立预测生物标志物。

结果

MLRC发生MLM的患者病理和影像T分期较晚,直肠周围脂肪含量较低(均P<0.05)。与其他类型复发转移患者相比,男性、肿瘤分化差、肿瘤N分期 advanced更易发生MLM(均P<0.05)。在Cox单因素和多因素回归分析中,较小的直肠PMT(风险比(HR)0.361[0.154-0.846],P=0.019)和MFEV(HR 0.983[0.968-0.998],P=0.022)与MLRC中的MLM独立相关(HR 0.361;0.983)。Kaplan-Meier分析显示,直肠PMT<1.43 cm和直肠MFEV<137.46 cm的患者与直肠PMT≥1.43 cm和直肠MFEV≥137.46 cm的患者相比,MLM风险显著更高(均P<0.05)。

结论

直肠PMT和直肠MFEV可作为预测MLRC患者MLM的新参数。

相似文献

1
Prediction of metachronous liver metastasis in mid-low rectal cancer using quantitative perirectal fat content from high-resolution MRI.利用高分辨率MRI定量直肠周围脂肪含量预测中低位直肠癌的异时性肝转移
Magn Reson Imaging. 2025 May;118:110338. doi: 10.1016/j.mri.2025.110338. Epub 2025 Jan 29.
2
Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer.中低位直肠肿瘤系膜内脂肪的定量评估:新的预后生物标志物。
Eur Radiol. 2019 Mar;29(3):1240-1247. doi: 10.1007/s00330-018-5723-5. Epub 2018 Sep 18.
3
Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.肌肉和脂肪组织参数与中低位直肠癌长期预后的相关性:一项回顾性队列研究。
Cancer Imaging. 2023 Jan 12;23(1):5. doi: 10.1186/s40644-022-00514-x.
4
Radiomics based on preoperative rectal cancer MRI to predict the metachronous liver metastasis.基于术前直肠癌MRI的影像组学预测异时性肝转移
Abdom Radiol (NY). 2023 Mar;48(3):833-843. doi: 10.1007/s00261-022-03773-1. Epub 2022 Dec 19.
5
Prognostic and Inflammatory Differences Between Upper and Mid-Lower Rectal Cancers in Non-Metastatic Stage II-II Disease.非转移性II-II期疾病中上下段直肠癌的预后及炎症差异
Curr Oncol. 2025 Apr 12;32(4):227. doi: 10.3390/curroncol32040227.
6
Machine Learning-based Analysis of Rectal Cancer MRI Radiomics for Prediction of Metachronous Liver Metastasis.基于机器学习的直肠癌 MRI 放射组学分析预测肝转移的研究。
Acad Radiol. 2019 Nov;26(11):1495-1504. doi: 10.1016/j.acra.2018.12.019. Epub 2019 Jan 30.
7
Radiomic Features of Mesorectal Fat as Indicators of Response in Rectal Cancer Patients Undergoing Neoadjuvant Therapy.新辅助治疗直肠癌患者中直肠系膜脂肪的影像组学特征作为反应指标
Tomography. 2025 Apr 7;11(4):44. doi: 10.3390/tomography11040044.
8
Multiparameter magnetic resonance imaging-based radiomics model for the prediction of rectal cancer metachronous liver metastasis.基于多参数磁共振成像的影像组学模型预测直肠癌异时性肝转移
World J Gastrointest Oncol. 2025 Jan 15;17(1):96598. doi: 10.4251/wjgo.v17.i1.96598.
9
The impact of mesorectal fat area on recurrence following total mesorectal excision for lower rectal cancer.直肠系膜脂肪面积对低位直肠癌全直肠系膜切除术后复发的影响。
Langenbecks Arch Surg. 2023 Apr 13;408(1):147. doi: 10.1007/s00423-023-02888-3.
10
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].经肛门全直肠系膜切除术与腹腔镜直肠系膜切除术治疗中低位直肠癌的安全性及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321.

引用本文的文献

1
Correlation between baseline magnetic resonance imaging features and serum carcinoembryonic antigen levels in patients with primary rectal cancer.原发性直肠癌患者基线磁共振成像特征与血清癌胚抗原水平的相关性
World J Gastrointest Oncol. 2025 Aug 15;17(8):108016. doi: 10.4251/wjgo.v17.i8.108016.